Literature DB >> 11168515

Increased vascularization in myeloma.

M Laroche1, P Brousset, I Ludot, B Mazières, M Thiechart, M Attal.   

Abstract

Several studies have shown that the number of intratumoral vessels can predict the aggressiveness of a solid cancer, development of metastases and patient survival. Does angiogenesis play an important role in myeloma? The aim of our study was to quantify bone marrow vascularity in various stages of proliferative plasma cell disorders (monoclonal gammopathies of undetermined significance (MGUS), stage I multiple myeloma (MM), stage III MM and Waldenström's macroglobulinemia (WM)) and to compare it with that of patients with osteoporosis. The study included 15 MGUS patients, 15 patients with stage I MM, 15 patients with symptomatic stage III MM, 7 patients with WM, 10 patients with osteoporosis, and 10 patients with reactive bone marrow (RBM), matched for sex and age. After iliac crest biopsy, the various vessels (arterioles, capillaries and sinusoids) were labeled with monoclonal antibodies CD34 and counted, and a histomorphometric study was done. The number of arterioles and arterial capillaries was significantly increased in MGUS and myeloma compared with osteoporosis. The number of arterioles and arterial capillaries increased moderately according to the stage of gravity of myeloma. The number of arterioles is negatively correlated with the trabecular bone volume and positively correlated with the eroded surfaces.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11168515     DOI: 10.1034/j.1600-0609.2001.00191.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  7 in total

Review 1.  Angiogenesis in hematologic malignancies and its clinical implications.

Authors:  Renchi Yang; Zhong Chao Han
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

Review 2.  Biological aspects of angiogenesis in multiple myeloma.

Authors:  Eléonore Otjacques; Marilène Binsfeld; Agnes Noel; Yves Beguin; Didier Cataldo; Jo Caers
Journal:  Int J Hematol       Date:  2011-11-17       Impact factor: 2.490

3.  The relation between bone marrow angiogenesis and the proliferation index Ki-67 in multiple myeloma.

Authors:  M G Alexandrakis; F H Passam; C Dambaki; C A Pappa; E N Stathopoulos
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

4.  Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells.

Authors:  S Lamorte; S Ferrero; S Aschero; L Monitillo; B Bussolati; P Omedè; M Ladetto; G Camussi
Journal:  Leukemia       Date:  2011-10-25       Impact factor: 11.528

5.  Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo.

Authors:  E Van Valckenborgh; H De Raeve; L Devy; S Blacher; C Munaut; A Noël; E Van Marck; I Van Riet; B Van Camp; K Vanderkerken
Journal:  Br J Cancer       Date:  2002-03-04       Impact factor: 7.640

6.  Angiogenic activity of multiple myeloma endothelial cells in vivo in the chick embryo chorioallantoic membrane assay is associated to a down-regulation in the expression of endogenous endostatin.

Authors:  Domenica Mangieri; Beatrice Nico; Vincenzo Benagiano; Michela De Giorgis; Angelo Vacca; Domenico Ribatti
Journal:  J Cell Mol Med       Date:  2008-06       Impact factor: 5.310

Review 7.  In Vitro Modeling of Non-Solid Tumors: How Far Can Tissue Engineering Go?

Authors:  Sandra Clara-Trujillo; Gloria Gallego Ferrer; José Luis Gómez Ribelles
Journal:  Int J Mol Sci       Date:  2020-08-11       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.